Buys | $0 | 0 | 0 |
Sells | $1,023,529 | 16 | 100 |
MCGUIRE TERRANCE | director | 0 | $0 | 16 | $1.02M | $-1.02M |
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research …
Over the last 12 months, insiders at Invivyd, Inc. have bought $0 and sold $1.02M worth of Invivyd, Inc. stock.
On average, over the past 5 years, insiders at Invivyd, Inc. have bought $0 and sold $10.39M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
2024-12-31 | Sale | MCGUIRE TERRANCE | director | 103,474 0.0894% | $0.45 | $46,098 | +106.48% | |
2024-12-30 | Sale | MCGUIRE TERRANCE | director | 86,545 0.0685% | $0.48 | $41,784 | +90.73% | |
2024-12-27 | Sale | MCGUIRE TERRANCE | director | 83,744 0.0705% | $0.52 | $43,647 | +65.86% | |
2024-12-26 | Sale | MCGUIRE TERRANCE | director | 83,817 0.0712% | $0.54 | $45,563 | +59.16% | |
2024-12-24 | Sale | MCGUIRE TERRANCE | director | 68,161 0.0566% | $0.51 | $34,503 | +65.23% | |
2024-12-23 | Sale | MCGUIRE TERRANCE | director | 75,776 0.0605% | $0.45 | $34,076 | +75.60% | |
2024-12-20 | Sale | MCGUIRE TERRANCE | director | 119,805 0.1005% | $0.42 | $50,725 | +82.92% | |
2024-12-19 | Sale | MCGUIRE TERRANCE | director | 152,067 0.1277% | $0.43 | $65,951 | +88.12% | |
2024-12-18 | Sale | MCGUIRE TERRANCE | director | 74,764 0.066% | $0.47 | $35,087 | +80.99% | |
2024-12-17 | Sale | MCGUIRE TERRANCE | director | 97,410 0.0782% | $0.48 | $46,757 | +38.95% | |
2024-12-16 | Sale | MCGUIRE TERRANCE | director | 65,359 0.0553% | $0.47 | $30,510 | +23.64% | |
2024-12-12 | Sale | MCGUIRE TERRANCE | director | 125,000 0.1041% | $0.58 | $72,875 | -5.67% | |
2024-12-11 | Sale | MCGUIRE TERRANCE | director | 160,400 0.135% | $0.59 | $94,812 | -5.48% | |
2024-12-10 | Sale | MCGUIRE TERRANCE | director | 175,000 0.1459% | $0.59 | $103,005 | -7.17% | |
2024-12-09 | Sale | MCGUIRE TERRANCE | director | 150,000 0.1261% | $0.61 | $91,560 | -3.65% | |
2024-05-29 | Sale | MCGUIRE TERRANCE | director | 112,381 0.2233% | $1.66 | $186,575 | -41.00% | |
2024-01-19 | Sale | Adimab, LLC | 10 percent owner | 5M 23.6347% | $3.95 | $19.75M | -74.47% |
Increased Positions | 36 | +42.35% | 14M | +19.15% |
Decreased Positions | 32 | -37.65% | 8M | -11.87% |
New Positions | 13 | New | 12M | New |
Sold Out Positions | 13 | Sold Out | 5M | Sold Out |
Total Postitions | 89 | +4.71% | 77M | +7.27% |
Maverick Capital Ltd | $9,471.00 | 9.81% | 11.77M | 0 | 0% | 2024-12-31 |
Mithril Ii Gp Lp | $9,049.00 | 9.37% | 11.24M | +11M | New | 2024-12-31 |
Deep Track Capital, Lp | $8,605.00 | 8.91% | 10.69M | -264,334 | -2.41% | 2024-12-31 |
M28 Capital Management Lp | $7,445.00 | 7.71% | 9.25M | 0 | 0% | 2024-12-31 |
Fmr Llc | $4,649.00 | 4.81% | 5.78M | -2M | -21.11% | 2024-12-31 |
Blackrock, Inc. | $3,819.00 | 3.95% | 4.74M | +71,833 | +1.54% | 2024-12-31 |
Vanguard Group Inc | $3,494.00 | 3.62% | 4.34M | -25,906 | -0.59% | 2024-12-31 |
Redmile Group, Llc | $2,425.00 | 2.51% | 3.01M | -53,460 | -1.74% | 2024-12-31 |
683 Capital Management, Llc | $2,415.00 | 2.5% | 3M | 0 | 0% | 2024-12-31 |
Bain Capital Life Sciences Investors, Llc | $1,449.00 | 1.5% | 1.8M | 0 | 0% | 2024-12-31 |